BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25366585)

  • 1. Postoperative Nomogram for Predicting Cancer-Specific Mortality in Medullary Thyroid Cancer.
    Ho AS; Wang L; Palmer FL; Yu C; Toset A; Patel S; Kattan MW; Tuttle RM; Ganly I
    Ann Surg Oncol; 2015 Aug; 22(8):2700-6. PubMed ID: 25366585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for predicting survival and recurrence in patients with adenoid cystic carcinoma. An international collaborative study.
    Ganly I; Amit M; Kou L; Palmer FL; Migliacci J; Katabi N; Yu C; Kattan MW; Binenbaum Y; Sharma K; Naomi R; Abib A; Miles B; Yang X; Lei D; Bjoerndal K; Godballe C; Mücke T; Wolff KD; Fliss D; Eckardt AM; Chiara C; Sesenna E; Ali S; Czerwonka L; Goldstein DP; Gil Z; Patel SG
    Eur J Cancer; 2015 Dec; 51(18):2768-76. PubMed ID: 26602017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative nomograms predictive of survival after surgical management of malignant tumors of the major salivary glands.
    Ali S; Palmer FL; Yu C; DiLorenzo M; Shah JP; Kattan MW; Patel SG; Ganly I
    Ann Surg Oncol; 2014 Feb; 21(2):637-42. PubMed ID: 24132626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years.
    Jung KY; Kim SM; Yoo WS; Kim BW; Lee YS; Kim KW; Lee KE; Jeong JJ; Nam KH; Lee SH; Hah JH; Chung WY; Yi KH; Park DJ; Youn YK; Sung MW; Cho BY; Park CS; Park YJ; Chang HS
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):587-97. PubMed ID: 26175307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience.
    Torresan F; Cavedon E; Mian C; Iacobone M
    World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Calcitonin-Negative Medullary Thyroid Carcinoma: A Case Series of 19 Patients in a Single Center.
    Kim SJ; Yun HJ; Shin SJ; Lee YS; Chang HS
    Front Endocrinol (Lausanne); 2021; 12():747704. PubMed ID: 34803914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to calcitonin normalization after surgery for node-negative and node-positive medullary thyroid cancer.
    Machens A; Lorenz K; Dralle H
    Br J Surg; 2019 Mar; 106(4):412-418. PubMed ID: 30725475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonographic Features of Medullary Thyroid Carcinoma: Do they Correlate with Pre and PostOperative Calcitonin Levels?
    Cho KE; Gweon HM; Park AY; Yoo MR; Kim J; Youk JH; Park YM; Son EJ
    Asian Pac J Cancer Prev; 2016; 17(7):3357-62. PubMed ID: 27509975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.
    Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M
    World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Static Prognostic Factors and Appropriate Surgical Designs for Patients with Medullary Thyroid Carcinoma: The Second Report from a Single-Institution Study in Japan.
    Ito Y; Miyauchi A; Kihara M; Higashiiyama T; Fukushima M; Miya A
    World J Surg; 2018 Dec; 42(12):3954-3966. PubMed ID: 30051240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
    Samulski TD; Livolsi VA; Montone K; Baloch Z
    Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic variables and calcitonin in medullary thyroid cancer.
    Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
    Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia.
    Ali S; Yu C; Palmer FL; Ganly I; Shaha A; Shah JP; Kattan MW; Patel SG
    Arch Otolaryngol Head Neck Surg; 2011 Nov; 137(11):1154-60. PubMed ID: 22106243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma.
    Cote GJ; Evers C; Hu MI; Grubbs EG; Williams MD; Hai T; Duose DY; Houston MR; Bui JH; Mehrotra M; Waguespack SG; Busaidy NL; Cabanillas ME; Habra MA; Luthra R; Sherman SI
    J Clin Endocrinol Metab; 2017 Sep; 102(9):3591-3599. PubMed ID: 28911154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pathological analysis of 19 cases of medullary thyroid carcinoma without an increase in calcitonin.
    Zhou Q; Yue S; Cheng Y; Jin J; Xu H
    Exp Toxicol Pathol; 2017 Oct; 69(8):575-579. PubMed ID: 28552629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Follow-up in Medullary Thyroid Carcinoma.
    Raue F; Frank-Raue K
    Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy.
    Kwon H; Kim WG; Jeon MJ; Song DE; Lee YM; Sung TY; Chung KW; Yoon JH; Hong SJ; Baek JH; Lee JH; Kim TY; Kim WB; Shong YK
    Endocrine; 2016 Jul; 53(1):174-81. PubMed ID: 26754662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma.
    Kuo EJ; Sho S; Li N; Zanocco KA; Yeh MW; Livhits MJ
    JAMA Surg; 2018 Jan; 153(1):52-59. PubMed ID: 28973144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node metastases and elevated postoperative calcitonin: Predictors of poor survival in medullary thyroid carcinoma.
    Siironen P; Hagström J; Mäenpää HO; Louhimo J; Arola J; Haglund C
    Acta Oncol; 2016; 55(3):357-64. PubMed ID: 26339947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
    Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
    J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.